Willis Towers Watson Public Limited Company operates as an advisory, broking, and solutions company worldwide. The company operates through two segments: Health, Wealth & Career and Risk & Broking. It offers strategy and design consulting, plan management service and support, broking and administration services for health, wellbeing, and other group benefit programs, including medical, dental, disability, life, voluntary benefits, and other coverages; actuarial support, plan design, and administrative services for pension and retirement savings plans; retirement consulting services and solutions; and integrated solutions that consists of investment discretionary management, pension administration, core actuarial, and communication and change management assistance services. The company also provides advice, data, software, and products to address clients' total rewards and talent issues; and risk advice, insurance brokerage, and consulting services in the areas of property and casualty, affinity, risk and analytics, aerospace, construction, global markets direct and facultative, financial, executive and professional risks, credit risk solutions, crisis management, surety, marine, and natural resources. In addition, it offers software and technology, risk and capital management, products and product pricing, financial and regulatory reporting, financial and capital modeling, M&A, outsourcing, and business management services. The company was formerly known as Willis Group Holdings Public Limited Company and changed its name to Willis Towers Watson Public Limited Company in January 2016. Willis Towers Watson Public Limited Company was founded in 1828 and is based in London, the United Kingdom.…
Will Synpulse Buyout Boost Marsh's Consulting Growth Prospects?
Willis Towers Watson (NASDAQ: WTW) is listed on Nasdaq, where its shares trade in USD. It belongs to the Insurance Brokers industry, part of the Financial Services sector, and reports about 48,100 employees.
The shares were at 331.01 USD on 20 November 2026, up 3.8% over 52 weeks. Its 52-week range is 240.61 USD to 351.17 USD: the price is 5.7% below the high and 37.6% above the low.
At a market capitalisation of 30.52B USD, it trades at 20.3 times trailing earnings and 14.4 times forward earnings. The median trailing P/E of its 17 largest Insurance Brokers peers is 24.7, a discount of 18% for WTW. It pays a dividend yielding 1.16% (it pays out 23% of its earnings), against a median of 2.46% among the dividend payers in that peer group.
Willis Towers Watson reports return on equity of 20.1%, an operating margin of 23.9% and revenue up 7.5% year over year.
Its debt exceeds its cash by 5.12B USD, a debt-to-equity ratio of 0.87. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 19 analysts cover the stock, with an average rating of Buy; their mean price target of 376.68 USD is 13.8% above the current price. The next earnings report is expected on 4 February 2027.